A recent study suggests that ITGA5 is overexpressed specifically in the tumor stroma of pancreatic cancer (mainly in CAFs or the activated PSCs), but has a low to negligible expression in cancer cells or normal pancreas 10. This evidence concerns the gene ITGA5 and neoplasm.